Cerner Co. (NASDAQ:CERN) Director Julie L. Gerberding sold 7,928 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $71.82, for a total value of $569,388.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

CERN traded down $3.75 on Friday, hitting $67.93. 3,773,664 shares of the company’s stock were exchanged, compared to its average volume of 2,452,552. The stock has a fifty day moving average of $72.68 and a two-hundred day moving average of $65.91. Cerner Co. has a twelve month low of $48.78 and a twelve month high of $76.47. The firm has a market cap of $22.73 billion, a PE ratio of 30.74, a P/E/G ratio of 2.04 and a beta of 0.92. The company has a current ratio of 2.52, a quick ratio of 2.50 and a debt-to-equity ratio of 0.22.

Cerner (NASDAQ:CERN) last issued its earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.02. The firm had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.44 billion. Cerner had a net margin of 10.75% and a return on equity of 15.14%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $0.62 earnings per share. On average, analysts predict that Cerner Co. will post 2.43 EPS for the current year.

The firm also recently declared a special dividend, which was paid on Friday, July 26th. Stockholders of record on Tuesday, June 18th were issued a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 17th. Cerner’s dividend payout ratio is currently 32.58%.

Several institutional investors have recently added to or reduced their stakes in the company. Acropolis Investment Management LLC lifted its holdings in Cerner by 2.0% during the 2nd quarter. Acropolis Investment Management LLC now owns 7,494 shares of the company’s stock valued at $549,000 after purchasing an additional 148 shares during the last quarter. Advisor Partners LLC raised its position in Cerner by 2.2% during the second quarter. Advisor Partners LLC now owns 7,061 shares of the company’s stock worth $518,000 after acquiring an additional 154 shares in the last quarter. Destination Wealth Management raised its position in Cerner by 3.7% during the second quarter. Destination Wealth Management now owns 5,208 shares of the company’s stock worth $382,000 after acquiring an additional 187 shares in the last quarter. Coastal Investment Advisors Inc. raised its position in shares of Cerner by 16.3% in the second quarter. Coastal Investment Advisors Inc. now owns 1,426 shares of the company’s stock valued at $104,000 after purchasing an additional 200 shares during the period. Finally, Berman Capital Advisors LLC raised its position in shares of Cerner by 115.3% in the second quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock valued at $27,000 after purchasing an additional 204 shares during the period. Institutional investors and hedge funds own 81.87% of the company’s stock.

CERN has been the subject of several recent research reports. BidaskClub raised Cerner from a “sell” rating to a “hold” rating in a research report on Thursday. Bank of America upped their target price on Cerner from $70.00 to $77.00 and gave the stock a “buy” rating in a research note on Tuesday, May 21st. Jefferies Financial Group downgraded Cerner from a “buy” rating to a “hold” rating and increased their price target for the stock from $69.00 to $75.00 in a research report on Friday. Wells Fargo & Co increased their price target on Cerner from $72.00 to $80.00 and gave the stock an “outperform” rating in a research report on Thursday, July 25th. Finally, Zacks Investment Research cut Cerner from a “buy” rating to a “hold” rating and set a $77.00 target price for the company. in a report on Monday, July 29th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $74.73.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Article: What is quantitative easing?

Insider Buying and Selling by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.